- Home
- NCLH vs QGEN Comparison
NCLH vs QGEN Comparison
Compare NCLH & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCLH
- QGEN
- Stock Information
- Founded
- NCLH 1966
- QGEN 1986
- Country
- NCLH United States
- QGEN Netherlands
- Employees
- NCLH N/A
- QGEN N/A
- Industry
- NCLH Marine Transportation
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NCLH Consumer Discretionary
- QGEN Health Care
- Exchange
- NCLH Nasdaq
- QGEN Nasdaq
- Market Cap
- NCLH 10.7B
- QGEN 10.7B
- IPO Year
- NCLH 2013
- QGEN 1996
- Fundamental
- Price
- NCLH $18.22
- QGEN $43.18
- Analyst Decision
- NCLH Buy
- QGEN Buy
- Analyst Count
- NCLH 17
- QGEN 7
- Target Price
- NCLH $29.65
- QGEN $50.68
- AVG Volume (30 Days)
- NCLH 18.6M
- QGEN 1.2M
- Earning Date
- NCLH 11-04-2025
- QGEN 11-04-2025
- Dividend Yield
- NCLH N/A
- QGEN 3.43%
- EPS Growth
- NCLH 11.76
- QGEN 334.36
- EPS
- NCLH 1.40
- QGEN 1.85
- Revenue
- NCLH $9,692,558,000.00
- QGEN $2,070,781,000.00
- Revenue This Year
- NCLH $8.20
- QGEN $7.37
- Revenue Next Year
- NCLH $10.58
- QGEN $5.65
- P/E Ratio
- NCLH $13.05
- QGEN $23.78
- Revenue Growth
- NCLH 3.59
- QGEN 5.32
- 52 Week Low
- NCLH $14.21
- QGEN $37.63
- 52 Week High
- NCLH $29.29
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- NCLH 18.39
- QGEN 27.38
- Support Level
- NCLH $21.84
- QGEN $43.26
- Resistance Level
- NCLH $22.76
- QGEN $47.39
- Average True Range (ATR)
- NCLH 0.74
- QGEN 1.09
- MACD
- NCLH -0.49
- QGEN -0.60
- Stochastic Oscillator
- NCLH 2.44
- QGEN 3.10
About NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).